Tumor necrosis factor-α converting enzyme inactivation ameliorates high-fat diet-induced insulin resistance and altered energy homeostasis

Hidehiro Kaneko, Toshihisa Anzai, Keisuke Horiuchi, Kokichi Morimoto, Atsushi Anzai, Toshiyuki Nagai, Yasuo Sugano, Yuichiro Maekawa, Hiroshi Itoh, Tsutomu Yoshikawa, Yasunori Okada, Satoshi Ogawa, Keiichi Fukuda

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Tumor necrosis factor (TNF)-α, which is released as a soluble form by ectodomain shedding of TNF-α converting enzyme (Tace), is known to play a pivotal role in obesity-induced insulin resistance. The role of Tace in obesity-induced metabolic disorders was to be clarified in this study. Methods and Results: Transgenic mice with temporal systemic Tace deletion (TaceMx1) and their non-transgenic littermates (CON) were fed a standard diet or a high-fat diet (HFD) from 6 weeks of age. The increased body, liver and epididymal adipose tissue (EAT) weights, systolic blood pressure, and fasting glucose and lipid levels and decreased serum adiponectin level 12 weeks after starting a HFD were suppressed by Tace inactivation. A HFD/ TaceMx1 showed ameliorated glucose tolerance and insulin sensitivity compared with HFD/CON. Indirect calorimetry showed that energy expenditure and oxidation of both fat and carbohydrate were higher in HFD/TaceMx1 than HFD/CON. Marked hepatosteatosis, increased triglyceride content and TNF-α expression in liver, and increased adipocyte size, macrophage infiltration and TNF-α and monocyte chemoattractant protein-1 expression in EAT induced by a HFD were attenuated in HFD/TaceMx1. Conclusions: Inactivation of Tace suppressed HFD-induced obesity, insulin resistance, hepatosteatosis and adipose tissue remodeling in association with increased energy expenditure, suggesting an important role of Tace in the development of obesity-induced metabolic disorders.

Original languageEnglish
Pages (from-to)2482-2490
Number of pages9
JournalCirculation Journal
Volume75
Issue number10
DOIs
Publication statusPublished - 2011 Oct

Fingerprint

High Fat Diet
Insulin Resistance
Homeostasis
Tumor Necrosis Factor-alpha
Enzymes
Obesity
Adipose Tissue
Energy Metabolism
Blood Pressure
Glucose
Indirect Calorimetry
Chemokine CCL2
Liver
Adiponectin
Adipocytes
Transgenic Mice
Fasting
Triglycerides
Fats
Macrophages

Keywords

  • Cytokine
  • Inflammation
  • Insulin resistance
  • Metabolism
  • Obesity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Tumor necrosis factor-α converting enzyme inactivation ameliorates high-fat diet-induced insulin resistance and altered energy homeostasis. / Kaneko, Hidehiro; Anzai, Toshihisa; Horiuchi, Keisuke; Morimoto, Kokichi; Anzai, Atsushi; Nagai, Toshiyuki; Sugano, Yasuo; Maekawa, Yuichiro; Itoh, Hiroshi; Yoshikawa, Tsutomu; Okada, Yasunori; Ogawa, Satoshi; Fukuda, Keiichi.

In: Circulation Journal, Vol. 75, No. 10, 10.2011, p. 2482-2490.

Research output: Contribution to journalArticle

Kaneko, H, Anzai, T, Horiuchi, K, Morimoto, K, Anzai, A, Nagai, T, Sugano, Y, Maekawa, Y, Itoh, H, Yoshikawa, T, Okada, Y, Ogawa, S & Fukuda, K 2011, 'Tumor necrosis factor-α converting enzyme inactivation ameliorates high-fat diet-induced insulin resistance and altered energy homeostasis', Circulation Journal, vol. 75, no. 10, pp. 2482-2490. https://doi.org/10.1253/circj.CJ-11-0182
Kaneko, Hidehiro ; Anzai, Toshihisa ; Horiuchi, Keisuke ; Morimoto, Kokichi ; Anzai, Atsushi ; Nagai, Toshiyuki ; Sugano, Yasuo ; Maekawa, Yuichiro ; Itoh, Hiroshi ; Yoshikawa, Tsutomu ; Okada, Yasunori ; Ogawa, Satoshi ; Fukuda, Keiichi. / Tumor necrosis factor-α converting enzyme inactivation ameliorates high-fat diet-induced insulin resistance and altered energy homeostasis. In: Circulation Journal. 2011 ; Vol. 75, No. 10. pp. 2482-2490.
@article{fc68293259704d39928ab196cda7cb92,
title = "Tumor necrosis factor-α converting enzyme inactivation ameliorates high-fat diet-induced insulin resistance and altered energy homeostasis",
abstract = "Background: Tumor necrosis factor (TNF)-α, which is released as a soluble form by ectodomain shedding of TNF-α converting enzyme (Tace), is known to play a pivotal role in obesity-induced insulin resistance. The role of Tace in obesity-induced metabolic disorders was to be clarified in this study. Methods and Results: Transgenic mice with temporal systemic Tace deletion (TaceMx1) and their non-transgenic littermates (CON) were fed a standard diet or a high-fat diet (HFD) from 6 weeks of age. The increased body, liver and epididymal adipose tissue (EAT) weights, systolic blood pressure, and fasting glucose and lipid levels and decreased serum adiponectin level 12 weeks after starting a HFD were suppressed by Tace inactivation. A HFD/ TaceMx1 showed ameliorated glucose tolerance and insulin sensitivity compared with HFD/CON. Indirect calorimetry showed that energy expenditure and oxidation of both fat and carbohydrate were higher in HFD/TaceMx1 than HFD/CON. Marked hepatosteatosis, increased triglyceride content and TNF-α expression in liver, and increased adipocyte size, macrophage infiltration and TNF-α and monocyte chemoattractant protein-1 expression in EAT induced by a HFD were attenuated in HFD/TaceMx1. Conclusions: Inactivation of Tace suppressed HFD-induced obesity, insulin resistance, hepatosteatosis and adipose tissue remodeling in association with increased energy expenditure, suggesting an important role of Tace in the development of obesity-induced metabolic disorders.",
keywords = "Cytokine, Inflammation, Insulin resistance, Metabolism, Obesity",
author = "Hidehiro Kaneko and Toshihisa Anzai and Keisuke Horiuchi and Kokichi Morimoto and Atsushi Anzai and Toshiyuki Nagai and Yasuo Sugano and Yuichiro Maekawa and Hiroshi Itoh and Tsutomu Yoshikawa and Yasunori Okada and Satoshi Ogawa and Keiichi Fukuda",
year = "2011",
month = "10",
doi = "10.1253/circj.CJ-11-0182",
language = "English",
volume = "75",
pages = "2482--2490",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "10",

}

TY - JOUR

T1 - Tumor necrosis factor-α converting enzyme inactivation ameliorates high-fat diet-induced insulin resistance and altered energy homeostasis

AU - Kaneko, Hidehiro

AU - Anzai, Toshihisa

AU - Horiuchi, Keisuke

AU - Morimoto, Kokichi

AU - Anzai, Atsushi

AU - Nagai, Toshiyuki

AU - Sugano, Yasuo

AU - Maekawa, Yuichiro

AU - Itoh, Hiroshi

AU - Yoshikawa, Tsutomu

AU - Okada, Yasunori

AU - Ogawa, Satoshi

AU - Fukuda, Keiichi

PY - 2011/10

Y1 - 2011/10

N2 - Background: Tumor necrosis factor (TNF)-α, which is released as a soluble form by ectodomain shedding of TNF-α converting enzyme (Tace), is known to play a pivotal role in obesity-induced insulin resistance. The role of Tace in obesity-induced metabolic disorders was to be clarified in this study. Methods and Results: Transgenic mice with temporal systemic Tace deletion (TaceMx1) and their non-transgenic littermates (CON) were fed a standard diet or a high-fat diet (HFD) from 6 weeks of age. The increased body, liver and epididymal adipose tissue (EAT) weights, systolic blood pressure, and fasting glucose and lipid levels and decreased serum adiponectin level 12 weeks after starting a HFD were suppressed by Tace inactivation. A HFD/ TaceMx1 showed ameliorated glucose tolerance and insulin sensitivity compared with HFD/CON. Indirect calorimetry showed that energy expenditure and oxidation of both fat and carbohydrate were higher in HFD/TaceMx1 than HFD/CON. Marked hepatosteatosis, increased triglyceride content and TNF-α expression in liver, and increased adipocyte size, macrophage infiltration and TNF-α and monocyte chemoattractant protein-1 expression in EAT induced by a HFD were attenuated in HFD/TaceMx1. Conclusions: Inactivation of Tace suppressed HFD-induced obesity, insulin resistance, hepatosteatosis and adipose tissue remodeling in association with increased energy expenditure, suggesting an important role of Tace in the development of obesity-induced metabolic disorders.

AB - Background: Tumor necrosis factor (TNF)-α, which is released as a soluble form by ectodomain shedding of TNF-α converting enzyme (Tace), is known to play a pivotal role in obesity-induced insulin resistance. The role of Tace in obesity-induced metabolic disorders was to be clarified in this study. Methods and Results: Transgenic mice with temporal systemic Tace deletion (TaceMx1) and their non-transgenic littermates (CON) were fed a standard diet or a high-fat diet (HFD) from 6 weeks of age. The increased body, liver and epididymal adipose tissue (EAT) weights, systolic blood pressure, and fasting glucose and lipid levels and decreased serum adiponectin level 12 weeks after starting a HFD were suppressed by Tace inactivation. A HFD/ TaceMx1 showed ameliorated glucose tolerance and insulin sensitivity compared with HFD/CON. Indirect calorimetry showed that energy expenditure and oxidation of both fat and carbohydrate were higher in HFD/TaceMx1 than HFD/CON. Marked hepatosteatosis, increased triglyceride content and TNF-α expression in liver, and increased adipocyte size, macrophage infiltration and TNF-α and monocyte chemoattractant protein-1 expression in EAT induced by a HFD were attenuated in HFD/TaceMx1. Conclusions: Inactivation of Tace suppressed HFD-induced obesity, insulin resistance, hepatosteatosis and adipose tissue remodeling in association with increased energy expenditure, suggesting an important role of Tace in the development of obesity-induced metabolic disorders.

KW - Cytokine

KW - Inflammation

KW - Insulin resistance

KW - Metabolism

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=80053085356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053085356&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-11-0182

DO - 10.1253/circj.CJ-11-0182

M3 - Article

C2 - 21785222

AN - SCOPUS:80053085356

VL - 75

SP - 2482

EP - 2490

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 10

ER -